Moors & Cabot’s Xylem XYL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.33M | Buy |
11,135
+1,770
| +19% | +$232K | 0.06% | 299 |
|
|
2025
Q4 | $1.28M | Buy |
9,365
+202
| +2% | +$29.1K | 0.05% | 297 |
|
|
2025
Q3 | $1.35M | Buy |
9,163
+275
| +3% | +$38.1K | 0.06% | 290 |
|
|
2025
Q2 | $1.15M | Buy |
8,888
+147
| +2% | +$17.8K | 0.05% | 307 |
|
|
2025
Q1 | $1.04M | Buy |
8,741
+630
| +8% | +$78.1K | 0.05% | 308 |
|
|
2024
Q4 | $941K | Buy |
8,111
+175
| +2% | +$22.1K | 0.04% | 345 |
|
|
2024
Q3 | $1.07M | Buy |
7,936
+104
| +1% | +$13.9K | 0.05% | 316 |
|
|
2024
Q2 | $1.06M | Buy |
7,832
+70
| +0.9% | +$9.52K | 0.06% | 292 |
|
|
2024
Q1 | $1M | Buy |
7,762
+220
| +3% | +$26.6K | 0.05% | 309 |
|
|
2023
Q4 | $862K | Buy |
7,542
+116
| +2% | +$11.6K | 0.05% | 307 |
|
|
2023
Q3 | $676K | Buy |
7,426
+251
| +3% | +$25.9K | 0.05% | 350 |
|
|
2023
Q2 | $808K | Hold |
7,175
| – | – | 0.05% | 314 |
|
|
2023
Q1 | $751K | Sell |
7,175
-166
| -2% | -$17.3K | 0.05% | 323 |
|
|
2022
Q4 | $812K | Buy |
7,341
+1
| +0% | +$105 | 0.06% | 310 |
|
|
2022
Q3 | $641K | Buy |
7,340
+1
| +0% | +$91 | 0.05% | 335 |
|
|
2022
Q2 | $574K | Sell |
7,339
-12
| -0.2% | -$991 | 0.04% | 380 |
|
|
2022
Q1 | $627K | Buy |
7,351
+513
| +8% | +$49.1K | 0.04% | 402 |
|
|
2021
Q4 | $820K | Buy |
6,838
+1
| +0% | +$124 | 0.05% | 334 |
|
|
2021
Q3 | $848K | Buy |
6,837
+1
| +0% | +$129 | 0.05% | 308 |
|
|
2021
Q2 | $820K | Sell |
6,836
-802
| -11% | -$91.6K | 0.06% | 307 |
|
|
2021
Q1 | $808K | Sell |
7,638
-214
| -3% | -$21.7K | 0.06% | 286 |
|
|
2020
Q4 | $799K | Sell |
7,852
-399
| -5% | -$37.5K | 0.07% | 266 |
|
|
2020
Q3 | $694K | Buy |
8,251
+263
| +3% | +$20.5K | 0.07% | 269 |
|
|
2020
Q2 | $515K | Buy |
7,988
+3,716
| +87% | +$245K | 0.05% | 309 |
|
|
2020
Q1 | $281K | Sell |
4,272
-3,692
| -46% | -$291K | 0.04% | 394 |
|
|
2019
Q4 | $629K | Sell |
7,964
-2,128
| -21% | -$166K | 0.06% | 290 |
|
|
2019
Q3 | $805K | Buy |
10,092
+427
| +4% | +$33.5K | 0.09% | 229 |
|
|
2019
Q2 | $810K | Sell |
9,665
-425
| -4% | -$33.9K | 0.1% | 210 |
|
|
2019
Q1 | $804K | Buy |
10,090
+1,000
| +11% | +$73K | 0.11% | 198 |
|
|
2018
Q4 | $602K | Sell |
9,090
-200
| -2% | -$13.8K | 0.09% | 225 |
|
|
2018
Q3 | $743K | Sell |
9,290
-77
| -0.8% | -$5.75K | 0.09% | 237 |
|
|
2018
Q2 | $628K | Sell |
9,367
-349
| -4% | -$25.3K | 0.08% | 261 |
|
|
2018
Q1 | $747K | Sell |
9,716
-1,675
| -15% | -$124K | 0.1% | 243 |
|
|
2017
Q4 | $775K | Sell |
11,391
-286
| -2% | -$19K | 0.1% | 230 |
|
|
2017
Q3 | $732K | Hold |
11,677
| – | – | 0.11% | 228 |
|
|
2017
Q2 | $650K | Buy |
11,677
+2,751
| +31% | +$143K | 0.11% | 232 |
|
|
2017
Q1 | $448K | Buy |
8,926
+1
| +0% | +$49 | 0.08% | 294 |
|
|
2016
Q4 | $443K | Hold |
8,925
| – | – | 0.07% | 309 |
|
|
2016
Q3 | $464K | Buy |
8,925
+566
| +7% | +$27.8K | 0.08% | 286 |
|
|
2016
Q2 | $372K | Sell |
8,359
-499
| -6% | -$21.7K | 0.07% | 317 |
|
|
2016
Q1 | $358K | Buy |
8,858
+600
| +7% | +$22.1K | 0.06% | 309 |
|
|
2015
Q4 | $300K | Buy |
8,258
+1
| +0% | +$36 | 0.05% | 351 |
|
|
2015
Q3 | $270K | Buy |
8,257
+501
| +6% | +$16.9K | 0.05% | 389 |
|
|
2015
Q2 | $291K | Buy |
+7,756
| New | +$282K | 0.05% | 392 |
|
Other funds holding XYL
VCM
VPM
Moors & Cabot's XYL Position: Q1 2026 in Review
Moors & Cabot increased its Xylem (XYL) stake by 19% in Q1 2026, buying an estimated $232K and bringing the position to 11,135 shares worth $1.33M. The position accounts for 0.06% of the portfolio, ranked #299.
Moors & Cabot first reported a position in XYL in Q2 2015 and has held it in 44 quarters since. The position peaked at $1.35M in Q3 2025. 1,109 funds tracked by Wall St. Rank hold XYL as of Q1 2026.
- Moors & Cabot held 11,135 shares of Xylem worth $1.33M as of Q1 2026.
- Moors & Cabot bought 1,770 Xylem shares in Q1 2026, an estimated $232K.
- Xylem made up 0.06% of Moors & Cabot's portfolio in Q1 2026, its #299 holding.
- Moors & Cabot first reported a position in Xylem in Q2 2015 and has held it in 44 quarters since.
- Moors & Cabot's Xylem position peaked at $1.35M in Q3 2025.
- 1,109 funds tracked by Wall St. Rank held Xylem as of Q1 2026.
Based on Moors & Cabot's 13F filing for Q1 2026, filed 8 May 2026.